Financhill
Sell
40

BIOX Quote, Financials, Valuation and Earnings

Last price:
$6.31
Seasonality move :
-0.02%
Day range:
$6.25 - $6.43
52-week range:
$5.71 - $14.05
Dividend yield:
0%
P/E ratio:
463.96x
P/S ratio:
0.92x
P/B ratio:
1.24x
Volume:
26.1K
Avg. volume:
228.9K
1-year change:
-53.7%
Market cap:
$383M
Revenue:
$464.8M
EPS (TTM):
$0.01

Analysts' Opinion

  • Consensus Rating
    Bioceres Crop Solutions has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Bioceres Crop Solutions has an estimated upside of 91.85% from its current price of $6.32.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $6.32.

Fair Value

  • According to the consensus of 0 analysts, Bioceres Crop Solutions has 91.85% upside to fair value with a price target of -- per share.

BIOX vs. S&P 500

  • Over the past 5 trading days, Bioceres Crop Solutions has underperformed the S&P 500 by -9.72% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Bioceres Crop Solutions does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Bioceres Crop Solutions revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bioceres Crop Solutions reported revenues of $92.6M.

Earnings Growth

  • Bioceres Crop Solutions earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bioceres Crop Solutions reported earnings per share of -$0.10.
Enterprise value:
630.9M
EV / Invested capital:
1.06x
Price / LTM sales:
0.92x
EV / EBIT:
24.86x
EV / Revenue:
1.43x
PEG ratio (5yr expected):
--
EV / Free cash flow:
51.65x
Price / Operating cash flow:
33.16x
Enterprise value / EBITDA:
13.38x
Gross Profit (TTM):
$177.5M
Return On Assets:
0.18%
Net Income Margin (TTM):
0.33%
Return On Equity:
0.43%
Return On Invested Capital:
0.25%
Operating Margin:
3.39%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $388.9M $408.8M $441.3M $116.2M $92.6M
Gross Profit $146.6M $171.5M $177.5M $42.7M $37.2M
Operating Income $46.4M $41.8M $40.4M $4.1M $3.1M
EBITDA $46.4M $52.8M $47.2M $9.6M $3.9M
Diluted EPS -$0.18 $0.18 $0.01 -$0.07 -$0.10
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $173.3M $263.7M $363M $395.4M $377.1M
Total Assets $309.5M $452.3M $785.3M $819.7M $827.3M
Current Liabilities $127.7M $202.4M $243.3M $311.7M $295.9M
Total Liabilities $248.3M $354.5M $470.5M $487.1M $481.2M
Total Equity $61.2M $97.8M $314.8M $332.6M $346M
Total Debt $163.1M $179.5M $227.9M $226.4M $249.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$36.2M $49.7M $32.1M $14.7M $5.2M
Cash From Investing $3.7M -$37.4M -$19.8M -$8.7M $271.8K
Cash From Financing $42.2M -$34.2M -$1.9M -$27M -$18.8M
Free Cash Flow -$47.5M $26M $12.2M $8.7M $2M
BIOX
Sector
Market Cap
$383M
$18.9M
Price % of 52-Week High
44.98%
57.66%
Dividend Yield
0%
0%
Shareholder Yield
-0.21%
1.61%
1-Year Price Total Return
-53.7%
-18.53%
Beta (5-Year)
0.514
1.064
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $6.46
200-day SMA
Sell
Level $9.83
Bollinger Bands (100)
Sell
Level 6.45 - 9.45
Chaikin Money Flow
Sell
Level -1.4M
20-day SMA
Sell
Level $6.67
Relative Strength Index (RSI14)
Sell
Level 42.65
ADX Line
Sell
Level 18.88
Williams %R
Neutral
Level -78.8347
50-day SMA
Sell
Level $6.72
MACD (12, 26)
Sell
Level -0.13
25-day Aroon Oscillator
Buy
Level 28
On Balance Volume
Neutral
Level 4.9M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.5864)
Sell
CA Score (Annual)
Level (-0.6708)
Buy
Beneish M-Score (Annual)
Level (-2.3616)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (3.5704)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Stock Forecast FAQ

In the current month, BIOX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BIOX average analyst price target in the past 3 months is --.

  • Where Will Bioceres Crop Solutions Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Bioceres Crop Solutions share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Bioceres Crop Solutions?

    Analysts are divided on their view about Bioceres Crop Solutions share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bioceres Crop Solutions is a Sell and believe this share price will drop from its current level to --.

  • What Is Bioceres Crop Solutions's Price Target?

    The price target for Bioceres Crop Solutions over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is BIOX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Bioceres Crop Solutions is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of BIOX?

    You can purchase shares of Bioceres Crop Solutions via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bioceres Crop Solutions shares.

  • What Is The Bioceres Crop Solutions Share Price Today?

    Bioceres Crop Solutions was last trading at $6.31 per share. This represents the most recent stock quote for Bioceres Crop Solutions. Yesterday, Bioceres Crop Solutions closed at $6.32 per share.

  • How To Buy Bioceres Crop Solutions Stock Online?

    In order to purchase Bioceres Crop Solutions stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock